Literature DB >> 10340909

Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer.

N L Tang1, C P Pang, W Yeo, K W Choy, P K Lam, M Suen, L K Law, W W King, P Johnson, M Hjelm.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10340909     DOI： 10.1093/jnci/91.10.882

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.

Authors:  V Abkevich; A Zharkikh; A M Deffenbaugh; D Frank; Y Chen; D Shattuck; M H Skolnick; A Gutin; S V Tavtigian
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  Cultural aspects of cancer genetics: setting a research agenda.

Authors:  B Meiser; M Eisenbruch; K Barlow-Stewart; K Tucker; Z Steel; D Goldstein
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

3.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Authors:  A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton
Journal:  Am J Hum Genet       Date:  2003-04-03       Impact factor: 11.025

4.  A novel frequent BRCA1 allele in Chinese patients with breast cancer.

Authors:  Dongxian Zhou; Wen Xiong; Hongxan Xu; Chaopeng Shao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer.

Authors:  Chuan-Gui Song; Zhen Hu; Jiong Wu; Jian-Min Luo; Zhen-Zhou Shen; Wei Huang; Zhi-Ming Shao
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-12       Impact factor: 4.553

6.  Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.

Authors:  Ava Kwong; Enders Kai On Ng; Chris Lei Po Wong; Fian Bic Fai Law; Tommy Au; Hong Nei Wong; Allison W Kurian; Dee W West; James M Ford; Edmond Siu Kwan Ma
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

7.  Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutations.

Authors:  S W Duffy; R M Nixon
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

8.  Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?

Authors:  Guo-Yan Liu; Wei Zhang
Journal:  Chin J Cancer       Date:  2011-12-16

9.  Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.

Authors:  E Thirthagiri; S Y Lee; P Kang; D S Lee; G T Toh; S Selamat; S-Y Yoon; N A Mohd Taib; M K Thong; C H Yip; S H Teo
Journal:  Breast Cancer Res       Date:  2008-07-16       Impact factor: 6.466

10.  BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history.

Authors:  Gaik Theng Toh; Peter Kang; Sharlene S W Lee; Daphne Shin-Chi Lee; Sheau Yee Lee; Suhaida Selamat; Nur Aishah Mohd Taib; Sook-Yee Yoon; Cheng Har Yip; Soo-Hwang Teo
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.